Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.
Endocrinology, Diabetes, Metabolism April 30th 2024
MDLinx
This study highlights the role of avocados in enhancing diet quality and vegetable intake among adults with obesity, with no associated weight gain, suggesting a viable strategy for dietary improvement.
All Specialties April 30th 2024
The New England Journal of Medicine
Semaglutide demonstrated a significant reduction in symptoms and weight among heart failure patients with diabetes, highlighted by a 7.3-point greater improvement in the Kansas City Cardiomyopathy Questionnaire clinical summary score compared to placebo.
Cardiology April 19th 2024
Medical News Today (MNT)
This study highlights the importance of evaluating the nutritional content of plant-based meat substitutes as they compare closely with traditional meats in terms of cardiometabolic health outcomes, with neither showing clear benefits over the other.
Cardiology April 17th 2024
Cleveland Clinic Journal of Medicine
This “From the Editor” in the Cleveland Clinic Journal of Medicine offers a nuanced view of corticosteroid therapy, highlighting the balance between their significant therapeutic benefits and the risk of adverse effects in long-term use.
Endocrinology, Diabetes, Metabolism April 15th 2024
Acquired reactive perforating collagenosis, characterized by pruritic eruptions and systemic associations, often manifests in patients with diabetes or chronic kidney disease, underscoring the necessity for holistic patient assessment in dermatological evaluations.
Dermatology April 15th 2024